Answers are grounded in this paper and cite their sources.
Most breast diseases are presented as mass lesions that can be easily detected by the patients or during clinical examination and breast imaging. Fine needle aspiration biopsy of the breast is an unquestionably useful test in differentiating various benign and malignant breast lesions however its diagnostic accuracy is still poorly known. Therefore, this study was conducted to evaluate the validity and diagnostic performance of fine needle aspiration cytology (FNAC) in diagnoses of breast masses and describe morphologic patterns of breast pathology in Hawassa University Comprehensive Specialized Hospital. This is a five years retrospective cross-sectional study of all breast lumps that underwent fine needle aspiration cytology and subsequent histopathology evaluation in the Department of Pathology, Hawassa university comprehensive specialized hospital Sidama, Ethiopia from September 2015 to August 2019. Sensitivity, specificity, positive and negative predictive value, and diagnostic accuracy were calculated and morphologic patterns of breast pathology were described. Fibroadenoma and invasive ductal carcinoma were the most common benign and malignant breast lesions, respectively. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of fine needle aspiration cytology of breast lumps were found to be 97.64%, 95.89%, 96.5%, 97.2%, and 96.8% respectively. FNAC is a valid method with high sensitivity and specificity for preoperative diagnosis of breast lesions, and we recommend the popularization of FNAC in our practice to complement histological diagnosis of breast lesions for early diagnosis and optimum treatment of our patients.
No takes yet. Share an insight, caveat, or question.
Senbeto et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: